Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivators

References

• Soreq H, Seidman S. Acetylcholinesterase–new role for an old actor. Natur Rev 2001;2: 294–302.
   PubMed Web of Science ®Google Scholar
• Pavlov VA, Wang H, Czura CJ, SG Friedman, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 2003;9: 125–134.
   PubMed Web of Science ®Google Scholar
• Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med 2005;6: 663–679.
   Google Scholar
• Van Der Zanden EP, Boeckxstaens GE, de Jonge WJ. The vagus nerve as a modulator of intestinal inflammation. Neurogastroenterol Motil 2009;21:6–17.
   PubMed Web of Science ®Google Scholar
• Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004;38:151–216.
   PubMed Web of Science ®Google Scholar
• Pohanka M, Musilek K, Kuca K. Progress of biosensors based on cholinesterase inhibition. Curr Med Chem 2009;16:1790–1798.
   PubMed Web of Science ®Google Scholar
• Organ G, Orhan I, Subutay-Oztekin N, Ak F, Sener B. Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer’s disease. Recent Pat CNS Drug Discov 2009;4:43–51.
   PubMedGoogle Scholar
• France JL, Posser T, Mattos JJ, Trevisan R, Brocardo RS, Rodriques AL, Leal RB, Farina M, Marques MR, Bainy AC, Dafre AL. Zinc reverses malathion-induced impairment in antioxidant defenses. Toxicol Lett 2009;187:137–143.
   PubMedGoogle Scholar
• Buyukguzel E. Evidence of oxidative and antioxidative responses by Galleria mellanella larvae to malathion. J Econ Entomol 2009;102:152–159.
   PubMed Web of Science ®Google Scholar
• Pohanka M, Zdarova-Karasova J, Musilek K, Kuca K, Kassa J. Effect of five acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efficacy. J Appl Toxicol 2009;29:483–488.
   PubMed Web of Science ®Google Scholar
• Musilek K, Holas O, Jun D, Dohnal V, Gunn-Moore F, Opletalova V, Dolezal M, Kuca K. Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem 2007;15:6733–6741.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney DK, Andreas V, Reastherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Pohanka M, Stetina R. Shift of oxidants and antioxidants levels in rats as a reaction to exposure to sulfur mustard. J Appl Toxicol 2009;29:643–647.
   PubMed Web of Science ®Google Scholar
• Supalkova V, Huska D, Diopan V, Hanustlak P, Zika O, Stejskal K, Baloun J, Pikula J, Havel L, Zehnalek J, Adam V, Trnkova L, Beklova M, Kizek R. Electroanalysis of plant thiols. Sensors 2007;7:932–952.
   Web of Science ®Google Scholar
• Chevion S, Roberts MA, Chevion M. The use of cyclic voltammetry for the evaluation of antioxidant capacity. Free Radic Biol Med 2000;28:860–870.
   PubMed Web of Science ®Google Scholar
• Pohanka M, Jun D, Kuca K. Improvement of acetylcholinesterase-based assay for organophosphates in way of identification by reactivators. Talanta 2008;77:451–454.
   PubMed Web of Science ®Google Scholar
• Kovarik Z, Calic M, Sinko G, Bosak A. Structure-activity approach in the reactivation of tabun-phosphorylated human acetylcholinesterase with bispyridinium para-aldoximes. Arh Hig Rada Toksikol 2007;58:201–209.
   PubMedGoogle Scholar
• Sinko G, Calic M, Bosak A, Kovarik Z. Limitation of the Ellman method: cholinesterase activity measurement in the presence of oximes. Anal Biochem 2007;370:223–227.
   PubMed Web of Science ®Google Scholar
• Pohanka M, Novotny L, Misik J, Kuca K, Zdarova-Krasova J, Hrabinova M. Evaluation of cholinesterase activites during in vivo intoxication using an electrochemical sensor strip–correlation with intoxication symptoms. Sensors 2009;9:3627–3634.
   PubMedGoogle Scholar
• Franco R, Schoneveld OJ, Pappa A, Pnaviotidis MI. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 2007;113:234–258.
   PubMedGoogle Scholar
• Markart P, Luboeinski TG, Korfei M, Schmidt R, Wygrecka M, Mahavadi P, Mayer K, Wilhelm J, Seeger W, Guenther A, Ruppert C. Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases. Antioxid Redox Signal 2009;11:227–240.
   PubMedGoogle Scholar
• Mares J, Palikova M, Kopp R, Navratil S, Pikula J. Changes in the nutritional parameters of muscles of the common carp (Cyprinus carpio) and the silver carp (Hypophthalmichthys molitrix) following environmental exposure to cyanobacterial water bloom. Aquacultur Res 2009;40:148–156.
   Google Scholar
• Skocovska B, Hilscherova K, Babica P, Adamovsky O, Bandouchova H, Horakova J, Knotkova Z, Marsalek B, Paskova V, Pikula J. Effects of cyanobacterial biomass on the Japanese quail. Toxicon 2007;49:793–803.
   PubMed Web of Science ®Google Scholar
• Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med 1996;2:1382–1385.
   PubMed Web of Science ®Google Scholar
• Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007;117:289–296.
   PubMed Web of Science ®Google Scholar
• Pavlov VA, Tracey KJ. The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005;19:493–499.
   PubMed Web of Science ®Google Scholar
• Lorke DE, Kalasz H, Petroianu GA, Tekes K. Entry of oximes into the brain: a review. Curr Med Chem 2008;15:743–753.
   PubMed Web of Science ®Google Scholar
• Jokanovic M, Prostran M. Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem 2009;16:2177–2188.
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Gardoni F, DiLuca M. Molecular rationale for the pharmacological treatment of Alzheimer’s disease. Drugs Aging 2005;22:27–37.
   PubMedGoogle Scholar
• Kassa J, Karasova J. A comparison of the potency of newly developed oximes (K047, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats. Drug Chem Toxicol 2007;30:117–131.
   PubMed Web of Science ®Google Scholar
• Ozen T, Tas M. Screening and evaluation of antioxidant activity of some amido-carbonyl oxime derivatives and their radical scavenging activities. J Enzyme Inhib Med Chem 2009;24:1141–1147.
   PubMed Web of Science ®Google Scholar
• Milatovic D, Gupta RC, Aschner M. Anticholinesterase toxicity and oxidative stress. The Scientific World Journal 2006;6:295–310.
   Web of Science ®Google Scholar
• Chiou SY, Huang CF, Yeh SJ, Chen IR, Lin G. Stereoselective inhibition of butyrylcholinesterase by enantiomers of exo-and endo-2-norbornyl-N-n-butylcarbamates. J Enzyme Inhib Med Chem 2010;25:13–20.
   PubMed Web of Science ®Google Scholar
• Haq Z, Hadi H, Moin ST, Choudhary MI. Molecular dynamics simulation of Axillaridine-A: a potent natural choinesterase inhibitor. J Enzyme Inhib Med Chem 2009;24:1101–1105.
   PubMedGoogle Scholar
• Suganthy N, Pandian SK, Devi KP. Cholinesterase inhibitory effects of Rhizophora lamarckii, Avicennia offcinalis, Sesuvium portulacastrum and Suaeda monica: mangroves inhabiting an Indian coastal area (Vellar Estuary). J Enzyme Inhib Med Chem 2009;24:702–707.
   PubMed Web of Science ®Google Scholar